Methyl 2-(4-bromo-3-methoxyphenyl)acetate, 95.0%, 1g

1-acetyl-4-amino-N-(pyridin-4-ylmethyl)piperidine-4-carboxamide hydrochloride, 100mg

4-(m-Tolyloxy)piperidine, 97%, 250mg

Sodium octadecane-1-sulfonate, 95+%, 1g

Benzyl 2-cyano-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95+%, 100mg

3-Fluoro-5-nitro-1-trifluoromethylbenzene, 95.0%, 5g

6-Phenylpyridazin-3(2H)-one, 95.0%, 25g

3,6-Dichloropicolinaldehyde, 95.0%, 5g

1-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate>98.0%(HPLC)(T)5g

2-Amino-3-methoxybenzoic acid, 97.0%, 100g

5-Bromo-3-chloro-2-(difluoromethyl)pyridine, 5g

Hydroxyde de potassium, min 85%, Ph.Eur., en pastilles, 2,5 kg, emballage plastique.

2-Ethoxy-6-methylpyridin-4-amine, 95.0%, 250mg